Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia four years ago. He was treated with a methylating agent While he was being treated with a hypomethylating agent, Rose researched investigational drugs being developed to treat relapsed/refractory AML.

    Two Sisters With Rare Diseases Are Working Towards Recovery With the Help of Their Family

    According to a recent article featured in News5Cleveland.com, there are over seven thousand rare diseases worldwide that affect over thirty million people in the United States. Several days ago, patients…

    Continue Reading Two Sisters With Rare Diseases Are Working Towards Recovery With the Help of Their Family
    A First: Human Clinical Trial Assessing Gene Therapy for Alzheimer’s Disease
    source: pixabay.com

    A First: Human Clinical Trial Assessing Gene Therapy for Alzheimer’s Disease

    Billions of dollars have been spent in research over decades, resulting in only two therapies that treat symptoms of Alzheimer’s disease (AD). There are no approved methods that diminish the…

    Continue Reading A First: Human Clinical Trial Assessing Gene Therapy for Alzheimer’s Disease
    The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer
    source: pixabay.com

    The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer

    Dr. Oliver Dorigo of the Stanford University Medical Center was the medical source for an article featured in Oncology. Dr. Dorigo explained that if a woman with ovarian cancer has…

    Continue Reading The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer
    Each New Discovery Brings Scientists Closer to Finding the Cause of Alzheimer’s Disease
    source: pixabay.com

    Each New Discovery Brings Scientists Closer to Finding the Cause of Alzheimer’s Disease

    Scientists are researching Alzheimer’s disease (AD) from all angles and gradually closing in on the cause of the disease. According to an article in Neuroscience News, a discovery by researchers…

    Continue Reading Each New Discovery Brings Scientists Closer to Finding the Cause of Alzheimer’s Disease
    Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease
    source: pixabay.com

    Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease

    Improving cognition and identifying abnormal molecular pathways in Alzheimer’s disease has been challenging. Current studies of Alzheimer’s disease have focused on reducing such occurrences as amyloid plaque, neuroinflammation, and neurofibrillary…

    Continue Reading Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease

    Sabatolimab Can Be Added Safely to Hypomethylating Agents in the Treatment of MDS and AML

    Dr. Andrew Brunner, an oncologist at Massachusetts Cancer Center was recently interviewed by Targeted Oncology. The discussion centered around a phase 1b clinical trial (NCT03066648) investigating sabatolimab together with hypomethylating…

    Continue Reading Sabatolimab Can Be Added Safely to Hypomethylating Agents in the Treatment of MDS and AML
    A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer
    source: pixabay.com

    A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer

      Toxoplasmosis is transmitted by Toxoplasma gondii, the protozoan parasite which is known to be among the most common parasites worldwide. The infection occurs from contaminated meat, cat feces that…

    Continue Reading A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer
    Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
    source: pixabay.com

    Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease

      There are many common elements in Alzheimer’s disease (AD), which is the most common type of dementia. It is now evident that there are varied spans of disease progression…

    Continue Reading Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease